{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "27490394", "DateCompleted": {"Year": "2017", "Month": "06", "Day": "12"}, "DateRevised": {"Year": "2022", "Month": "03", "Day": "11"}, "Article": {"ArticleDate": [{"Year": "2016", "Month": "08", "Day": "04"}], "ELocationID": ["e0004908", "10.1371/journal.pntd.0004908"], "Language": ["eng"], "Journal": {"ISSN": "1935-2735", "JournalIssue": {"Volume": "10", "Issue": "8", "PubDate": {"Year": "2016", "Month": "Aug"}}, "Title": "PLoS neglected tropical diseases", "ISOAbbreviation": "PLoS Negl Trop Dis"}, "ArticleTitle": "Compounds Derived from the Bhutanese Daisy, Ajania nubigena, Demonstrate Dual Anthelmintic Activity against Schistosoma mansoni and Trichuris muris.", "Pagination": {"StartPage": "e0004908", "MedlinePgn": "e0004908"}, "Abstract": {"AbstractText": ["Whipworms and blood flukes combined infect almost one billion people in developing countries. Only a handful of anthelmintic drugs are currently available to treat these infections effectively; there is therefore an urgent need for new generations of anthelmintic compounds. Medicinal plants have presented as a viable source of new parasiticides. Ajania nubigena, the Bhutanese daisy, has been used in Bhutanese traditional medicine for treating various diseases and our previous studies revealed that small molecules from this plant have antimalarial properties. Encouraged by these findings, we screened four major compounds isolated from A. nubigena for their anthelmintic properties.", "Here we studied four major compounds derived from A. nubigena for their anthelmintic properties against the nematode whipworm Trichuris muris and the platyhelminth blood fluke Schistosoma mansoni using the xWORM assay technique. Of four compounds tested, two compounds-luteolin (3) and (3R,6R)-linalool oxide acetate (1)-showed dual anthelmintic activity against S. mansoni (IC50 range = 5.8-36.9 \u03bcg/mL) and T. muris (IC50 range = 9.7-20.4 \u03bcg/mL). Using scanning electron microscopy, we determined luteolin as the most efficacious compound against both parasites and additionally was found effective against the schistosomula, the infective stage of S. mansoni (IC50 = 13.3 \u03bcg/mL). Luteolin induced tegumental damage to S. mansoni and affected the cuticle, bacillary bands and bacillary glands of T. muris. Our in vivo assessment of luteolin (3) against T. muris infection at a single oral dosing of 100 mg/kg, despite being significantly (27.6%) better than the untreated control group, was markedly weaker than mebendazole (93.1%) in reducing the worm burden in mice.", "Among the four compounds tested, luteolin demonstrated the best broad-spectrum activity against two different helminths-T. muris and S. mansoni-and was effective against juvenile schistosomes, the stage that is refractory to the current gold standard drug, praziquantel. Medicinal chemistry optimisation including cytotoxicity analysis, analogue development and structure-activity relationship studies are warranted and could lead to the identification of more potent chemical entities for the control of parasitic helminths of humans and animals."]}, "AuthorList": [{"Identifier": ["0000-0002-4381-7382"], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Biodiscovery and Molecular Development of Therapeutics, Queensland Tropical Health Alliance, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns Campus, Cairns, Australia."}], "LastName": "Wangchuk", "ForeName": "Phurpa", "Initials": "P"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Biodiscovery and Molecular Development of Therapeutics, Queensland Tropical Health Alliance, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns Campus, Cairns, Australia."}], "LastName": "Pearson", "ForeName": "Mark S", "Initials": "MS"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Biodiscovery and Molecular Development of Therapeutics, Queensland Tropical Health Alliance, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns Campus, Cairns, Australia."}], "LastName": "Giacomin", "ForeName": "Paul R", "Initials": "PR"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Biodiscovery and Molecular Development of Therapeutics, Queensland Tropical Health Alliance, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns Campus, Cairns, Australia."}], "LastName": "Becker", "ForeName": "Luke", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Biodiscovery and Molecular Development of Therapeutics, Queensland Tropical Health Alliance, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns Campus, Cairns, Australia."}], "LastName": "Sotillo", "ForeName": "Javier", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Biodiscovery and Molecular Development of Therapeutics, Queensland Tropical Health Alliance, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns Campus, Cairns, Australia."}], "LastName": "Pickering", "ForeName": "Darren", "Initials": "D"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Biodiscovery and Molecular Development of Therapeutics, Queensland Tropical Health Alliance, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns Campus, Cairns, Australia."}], "LastName": "Smout", "ForeName": "Michael J", "Initials": "MJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Centre for Biodiscovery and Molecular Development of Therapeutics, Queensland Tropical Health Alliance, Australian Institute of Tropical Health and Medicine, James Cook University, Cairns Campus, Cairns, Australia."}], "LastName": "Loukas", "ForeName": "Alex", "Initials": "A"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS Negl Trop Dis", "NlmUniqueID": "101291488", "ISSNLinking": "1935-2727"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anthelmintics"}, {"RegistryNumber": "0", "NameOfSubstance": "Plant Extracts"}, {"RegistryNumber": "6490C9U457", "NameOfSubstance": "Praziquantel"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Anthelmintics"}, {"QualifierName": ["chemistry"], "DescriptorName": "Asteraceae"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": [], "DescriptorName": "Male"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": [], "DescriptorName": "Microscopy, Electron, Scanning"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Plant Extracts"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["pharmacology"], "DescriptorName": "Praziquantel"}, {"QualifierName": ["drug effects"], "DescriptorName": "Schistosoma mansoni"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Schistosomiasis mansoni"}, {"QualifierName": [], "DescriptorName": "Structure-Activity Relationship"}, {"QualifierName": ["drug therapy"], "DescriptorName": "Trichuriasis"}, {"QualifierName": ["drug effects"], "DescriptorName": "Trichuris"}], "CoiStatement": "The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": " WHO. Neglected tropical diseases (NTDs). 2015a. Available: http://www.who.int/neglected_diseases/diseases/en/23/2/15."}, {"Citation": "Panic G, Duthaler U, Speich B, Keiser J. Repurposing drugs for the treatment and control of helminth infections. Int J Parasitol Drugs Drug Resist. 2014; 4: 185\u2013200. 10.1016/j.ijpddr.2014.07.002", "ArticleIdList": ["10.1016/j.ijpddr.2014.07.002", "PMC4266803", "25516827"]}, {"Citation": "USAID. Whipworm (Trichuris trichiura or Trichocephalus trichuris). 2014. Available:http://www.neglecteddiseases.gov/target_diseases/soil_transmitted_helminthiasis/whipworm/index.html/5/3/15."}, {"Citation": "WHO. Schistosomiasis: A major public health problem. Available: http://www.who.int/schistosomiasis/en/23/2/15."}, {"Citation": "Morel M, Vanderstraete M, Cailliau K, Lescuyer A, Lancelot J, Dissous C. Compound library screening identified Akt/PKB kinase pathway inhibitors as potential key molecules for the development of new chemotherapeutics against schistosomiasis. Int J Parasitol Drugs Drug Resist. 2014; 4: 256\u2013266. 10.1016/j.ijpddr.2014.09.004", "ArticleIdList": ["10.1016/j.ijpddr.2014.09.004", "PMC4266776", "25516836"]}, {"Citation": "Pedrique B, Strub-Wourgaft N, Some C, Olliaro P, Trouiller P, Ford N, P\u00e9coul B, Bradol JH. The drug and vaccine landscape for neglected diseases (2000\u201311): a systematic assessment. The Lancet Global Health. 2013; 1: e371\u2013e379. 10.1016/S2214-109X(13)70078-0", "ArticleIdList": ["10.1016/S2214-109X(13)70078-0", "25104602"]}, {"Citation": "Keiser J, Utzinger J. Efficacy of current drugs against soil-transmitted helminth infections: systematic review and meta-analysis. JAMA. 2008; 299: 1937\u20131948. 10.1001/jama.299.16.1937", "ArticleIdList": ["10.1001/jama.299.16.1937", "18430913"]}, {"Citation": "Wolstenholme AJ, Martin RJ. Anthelmintics-From discovery to resistance. Int J Parasitol Drugs Drug Resist. 2014; 4: 218\u2013219. 10.1016/j.ijpddr.2014.10.001", "ArticleIdList": ["10.1016/j.ijpddr.2014.10.001", "PMC4266783", "25516831"]}, {"Citation": "Matthews J. Mitigating anthelmintic resistance in equine nematodes. Int J Parasitol Drugs Drug Resist. 2014; 4: 310\u2013315. 10.1016/j.ijpddr.2014.10.003", "ArticleIdList": ["10.1016/j.ijpddr.2014.10.003", "PMC4266799", "25516842"]}, {"Citation": "Wang W, Wang L, Liang YS. Suceptibility or resistance of praziquantel in human schistosomiasis: a review. Parasitol Res. 2012; 111: 1871\u20131877. 10.1007/s00436-012-3151-z", "ArticleIdList": ["10.1007/s00436-012-3151-z", "23052781"]}, {"Citation": "Mwangi IN, Sanchez MC, Mkoji GM, Agola LE, Runo SM, Cupit PM, Cunningham C. Praziquantel sensitivity of Kenyan Schistosoma mansoni isolates and the generation of a laboratory strain with reduced susceptibility to the drug. Int J Parasitol Drugs Drug Resist. 2014; 4: 296\u2013300. 10.1016/j.ijpddr.2014.09.006", "ArticleIdList": ["10.1016/j.ijpddr.2014.09.006", "PMC4266778", "25516840"]}, {"Citation": "Stothard JR, Sousa-Figueiredo JC, Betson M, Bustinduy A, Reinhard-Rupp J. Schistosomiasis in African infants and preschool children: let them now be treated! Trends Parasitol. 2013; 29: 197\u2013205. 10.1016/j.pt.2013.02.001", "ArticleIdList": ["10.1016/j.pt.2013.02.001", "PMC3878762", "23465781"]}, {"Citation": "Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nat Rev Drug Discov. 2015; 2:111\u201329.", "ArticleIdList": ["25614221"]}, {"Citation": "Lai H, Sasaki T, Singh NP. Targeted treatment of cancer with artemisinin and artemisinin tagged iron-carrying compounds. Expert Opin Ther Targets. 2005; 9: 995\u20131007.", "ArticleIdList": ["16185154"]}, {"Citation": "Athanasiadou S, Githiori J, Kyriazakis I. Medicinal plants for helminth parasite control: facts and fiction. Animal. 2007; 1: 1392\u20131400. 10.1017/S1751731107000730", "ArticleIdList": ["10.1017/S1751731107000730", "22444894"]}, {"Citation": "Wangchuk P, Keller PA, Pyne SG, Taweechotipatr M, Tonsomboon A, Rattanajak R, Kamchonwongpaisan S. Evaluation of an ethnopharmacologically selected Bhutanese medicinal plants for their major classes of phytochemicals and biological activities. J Ethnopharmacol. 2011; 137: 730\u2013742. 10.1016/j.jep.2011.06.032", "ArticleIdList": ["10.1016/j.jep.2011.06.032", "21741462"]}, {"Citation": "Wangchuk P, Keller PA, Pyne SG, Willis AC, Kamchonwongpaisan S. Antimalarial alkaloids from a Bhutanese traditional medicinal plant Corydalis dubia. J Ethnopharmacol. 2012; 143: 310\u2013313. 10.1016/j.jep.2012.06.037", "ArticleIdList": ["10.1016/j.jep.2012.06.037", "22796506"]}, {"Citation": "Wangchuk P, Keller PA, Pyne SG, Lie W, Willis AC, Rattanajak R, Kamchonwongpaisan S. A new protoberberine alkaloid from Meconopsis simplicifolia (D. Don) Walpers with potent antimalarial activity against a multidrug resistant Plasmodium falciparum strain. J Ethnopharmacol. 2013a; 150: 953\u2013959.", "ArticleIdList": ["24120516"]}, {"Citation": "Wangchuk P, Pyne SG, Keller PA, Taweechotipatr M, Kamchonwongpaisan S. Phenylpropanoids and furanocoumarins as antibacterial and antimalarial constituents of the Bhutanese medicinal plant Pleurospermum amabile. Nat Prod Commun. 2014; 9: 957\u2013960.", "ArticleIdList": ["25230503"]}, {"Citation": "Edwards J, Brown M, Peak E, Bartholomew B, Nash RJ, Hoffman KF. The diterpenoid 7-Keto-sempervirol, derived from Lycium chinense, displays anthelmintic activity against both Schistosoma mansoni and Fasciola hepatica. PLoS Negl Trop Dis. 2015; 10.1371/journal.pntd.0003604", "ArticleIdList": ["10.1371/journal.pntd.0003604", "PMC4358835", "25768432"]}, {"Citation": "Wangchuk P, Keller PA, Pyne SG, Korth J, Samten Taweechotipatr M, Rattanajak R, Kamchonwongpaisan S. Antimicrobial, antimalarial and cytotoxicity activities of constituents of a Bhutanese variety of Ajania nubigena. Nat Prod Commun. 2013b; 8: 733\u2013736."}, {"Citation": "Ballabh B, Chaurasa OP. Medicinal plants of cold desert Ladakh used in the treatment of stomach disorders. Indian J Tradit Know. 2009; 8: 185\u2013190."}, {"Citation": "Pareek A, Suthar M, Rathore GS, Bansal V. Feverfew (Tanacetum parthenium L.): A systematic review. Pharmacogn Rev. 2011; 5:103\u201310. 10.4103/0973-7847.79105", "ArticleIdList": ["10.4103/0973-7847.79105", "PMC3210009", "22096324"]}, {"Citation": "Smout M, Kotze AC, McCarthy JS, Loukas A. A novel high throughput assay for anthelmintic drug screening and resistance diagnosis by real-time monitoring of parasite motility. PLOS Negl Trop Dis. 2010; 4: e885 10.1371/journal.pntd.0000885", "ArticleIdList": ["10.1371/journal.pntd.0000885", "PMC2982823", "21103363"]}, {"Citation": "Rinaldi G, Loukas A, Brindley PJ, Irelan PJ, Smout MJ. Viability of developmental stages of Schistosoma mansoni quantified with xCELLigence worm real-time motility assay (xWORM). Int J Parasitol Drugs Drug Resist. 2015; 5: 141\u2013148. 10.1016/j.ijpddr.2015.07.002", "ArticleIdList": ["10.1016/j.ijpddr.2015.07.002", "PMC4534758", "26288742"]}, {"Citation": "Harn DA, Mitsuyama M, David JR. Schistosoma mansoni: anti-egg monoclonal antibody protects against cercarial challenge in vivo. J Exp Med. 1984; 159: 1371\u20131387.", "ArticleIdList": ["PMC2187298", "6538899"]}, {"Citation": "Basch PF. Cultivation of Schistosoma mansoni in vitro. I. Establishment of cultures from cercariae and development until pairing. J Parasitol. 1981; 67: 179\u2013185.", "ArticleIdList": ["7241277"]}, {"Citation": "Peak E, Chalmers IW, Hoffmann KF. Development and validation of a quantitative, high-throughput, fluorescent-based bioassay to detect Schistosoma viability. PloS Negl Trop Dis. 2010; 4: e759 10.1371/journal.pntd.0000759", "ArticleIdList": ["10.1371/journal.pntd.0000759", "PMC2910722", "20668553"]}, {"Citation": "Rajasekariah GR, Deb BN, Jones MP, Dhage KR, Bose S. Response of pre-adult and adult stages of Trichuris muris to common anthelmintics in mice. Int J Parasitol. 1991; 21: 697\u2013702.", "ArticleIdList": ["1757197"]}, {"Citation": "Stepek G, Lowe AE, Buttle DJ, Duce IR, Behnke JM. In vitro and in vivo anthelmintic efficacy of plant cysteine proteinases against the rodent gastrointestinal nematode, Trichuris muris. Parasitology. 2006; 132: 681\u2013689.", "ArticleIdList": ["16448585"]}, {"Citation": "Tritten L, Silbereisen A, Keiser J. Nitazoxanide: In vitro and in vivo drug effects against Trichuris muris and Ancyclostoma ceylanicum, alone or in combination. Int J Parasitol Drugs Drug Resist. 2012; 2: 98\u2013105. 10.1016/j.ijpddr.2012.02.004", "ArticleIdList": ["10.1016/j.ijpddr.2012.02.004", "PMC3862390", "24533270"]}, {"Citation": "De Oliveira CNF, de Oliveira RN, Frezza TF, Rehder VLG, Allergretti SM. Tegument of Schistosoma mansoni as a therapeutic target In: INTECH open science; 2013. pp.152\u2013177. Available: 10.5772/53653.", "ArticleIdList": ["10.5772/53653"]}, {"Citation": "Becker B, Mehlhom H, Andrews P, Thomas H, Eckert J. Light and electron microscopic studies on the effect of praziquantel on Schistosoma mansoni, Dicrocoelium dendriticum, and Fasciola hepatica (Trematoda) in vitro. Z Parasitenkd. 1980; 63: 113\u2013128.", "ArticleIdList": ["7456640"]}, {"Citation": "Kohn A, Lopez-Alvarez ML, Katz N. Transmission and scanning electron microscopical studies in the tegument of male Schistosoma mansoni after oxamniquine treatment. Ann Parasitol Hum Comp. 1982; 57: 285\u2013291.", "ArticleIdList": ["7137803"]}, {"Citation": "Shaw MK, Erasmus DA. Schistosoma mansoni: changes in elemental composition in relation to the age and sexual status of the worms. Parasitology. 1983; 86: 439\u2013453.", "ArticleIdList": ["6877870"]}, {"Citation": "Brickes CS, Depenbusch JW, Benett JL, Thompson DF. The relationship between tegumental disruption and muscle contraction in Schistosoma mansoni exposed to various compounds. Parasitol Res. 1983; 69: 61\u201367.", "ArticleIdList": ["6837102"]}, {"Citation": "Manneck T, Haggenmuller Y, Keiser J. Morphological effects and tegumental alterations induced by mefloquine on schistosomula and adult flukes of Schistosomula and adult flukes of Schistosoma mansoni. Parasitology. 2010; 137: 85\u201398. 10.1017/S0031182009990965", "ArticleIdList": ["10.1017/S0031182009990965", "19814844"]}, {"Citation": "Abdul-Ghani R, Loutfy N, Sheta M, Hassan A. Artemether shows promising female schistosomacidal and ovicidal effects on the Egyptian strain of Schistosoma mansoni after maturity of infection. Parasitol Res. 2011; 108: 1199\u20131205. 10.1007/s00436-010-2163-9", "ArticleIdList": ["10.1007/s00436-010-2163-9", "21107863"]}, {"Citation": "Zhang SM, Coultas KA. Identification of plumbagin and sanguinarine as effective chemotherapeutic agents for treatment of schistosomiasis. Int J Parasitol Drugs Drug Resist. 2013; 3: 28\u201334.", "ArticleIdList": ["PMC3638872", "23641325"]}, {"Citation": "Matadamas-Mart\u00ednez F, Nogueda-Torres B, Hern\u00e1ndez-Campos A, Hern\u00e1ndez-Luis F, Castillo R, Mendoza G, Ambrosio JR, Andr\u00e9s-Antonio G, Y\u00e9pez-Mulia L. Analysis of the effect of a 2-(trifluoromethyl)-1H-benzimidazole derivative on Trichinella spiralis muscle larvae. Vet Parasitol. 2013; 194: 193\u2013197. 10.1016/j.vetpar.2013.01.054", "ArticleIdList": ["10.1016/j.vetpar.2013.01.054", "23462252"]}, {"Citation": "Hanser E, Mehlhorn H, Hoeben D, Vlaminck K. In vitro studies on the effects of flubendazole against Toxocara canis and Ascaris suum. Parasitol Res. 2003; 89: 63\u201374.", "ArticleIdList": ["12474046"]}, {"Citation": "Wright KA, Chan J. Sense receptors in the bacillary band of trichuroid nematodes. Tissue Cell. 1973; 5: 373\u201380.", "ArticleIdList": ["4744677"]}, {"Citation": "Lee TDG, Wright KA. The morphology of the attachment and probable feeding site of the nematode Trichuris muris (Schrank, 1788) Hall, 1916. Can J Zool. 1978; 56: 1889\u20131905.", "ArticleIdList": ["737601"]}, {"Citation": "Huttemann M, Schmahl G, Mehlhorn H. Light and electron microscopic studies on two nematodes, Angiostrongylus cantonensis and Trichuris muris, differing in their mode of nutrition. Parasitol Res. 2007; 101: S225\u2013S232. 10.1007/s00436-007-0698-1", "ArticleIdList": ["10.1007/s00436-007-0698-1", "17823832"]}, {"Citation": "Torres EJL, de Souza W, Miranda K. Comparative analysis of Trichuris muris surface using conventional, low vacuum, environmental and field emission scanning electron microscopy. Vet Parasitol. 2013; 196: 409\u2013416. 10.1016/j.vetpar.2013.02.026", "ArticleIdList": ["10.1016/j.vetpar.2013.02.026", "23537947"]}, {"Citation": "Lipinski CA, Lombardo F, Dominy BW, Feeney PJ. Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv Drug Deliv Rev. 2001; 46: 3\u201326.", "ArticleIdList": ["11259830"]}], "ReferenceList": []}], "History": [{"Year": "2016", "Month": "2", "Day": "2"}, {"Year": "2016", "Month": "7", "Day": "15"}, {"Year": "2016", "Month": "8", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "8", "Day": "5", "Hour": "6", "Minute": "0"}, {"Year": "2017", "Month": "6", "Day": "13", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "8", "Day": "4"}], "PublicationStatus": "epublish", "ArticleIdList": ["27490394", "PMC4973903", "10.1371/journal.pntd.0004908", "PNTD-D-16-00180"]}}], "PubmedBookArticle": []}